Celgene (CELG) Growth Rates Comparisons to Major Pharmaceutical Preparations Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Industry, else..
 
Celgene Corp  (NASDAQ: CELG)
 

Celgene Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CELG Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q3 MRQ) 16.14 % 4.92 % 4.59 % 3.04 %
Q / Q Revenue Growth (Q3 MRQ) 2.73 % -6.57 % -2.44 % 0.28 %
Y / Y Revenue Growth (for 12 months ending Q3 TTM) 15.31 % 3.56 % 3.29 % %
Sequential Revenue Growth (for 12 months ending Q3 TTM) 3.84 % 1.18 % 1.08 % 0.75 %
Revenue 5 Year Average Growth 18.67 % 13.18 % 9.12 % 9.52 %


CELG's Growth Comparisons in III. Quarter 2019




Celgene improved it's Revenue by 16.14% year on year in the third quarter 2019, and outpaced the 4.92% growth in the Major Pharmaceutical Preparations industry, and 4.59% growth in the Healthcare sector. Above the average sales gains in the Healthcare and in the Major Pharmaceutical Preparations industry, helped to elevate overall market growth to 3.04%.

Comparing the company's Revenue to the second quarter results, sales were higher by 2.73% . On the yearly basis, average annual sales growth for Celgene is 18.67%, while S & P 500's including only Businesses with the third quarter 2019 earnings, average annual sales growth is 9.52% over the past five years.

CELG Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
ABRAXANE
-
-


Growth Rates of CELG's Income in the third quarter 2019


CELG Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q3 MRQ) 34.76 % 45.94 % 54.01 % 1.12 %
Sequential Operating Income Change (Q3 MRQ) 7.25 % 33.39 % 4.1 % -12.02 %
Y / Y Operating Income Growth (Q3 TTM) 72.05 % 36.52 % 6.11 % -9.06 %
Sequential Operating Income Growth (Q3 TTM) 7.99 % 14.41 % 18.96 % 2.07 %
Operating Income 5 Year Avg. Change 23.47 % 2.86 % 2.86 % 11.15 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q3 MRQ) 56.28 % 0.82 % -14.81 % -6.67 %
Sequential Income from Cont. Ops. Change (Q3 MRQ) 7.64 % 3.47 % -11.95 % -5.84 %
Y / Y Income from Cont. Ops. Change (Q3 TTM) 103.32 % 59.78 % 64.62 % 12.73 %
Sequential Income from Cont. Ops. Change (Q3 TTM) 11.55 % 0.07 % -3.77 % -1.01 %
Income from Cont. Ops. 5 Year Avg. Change 22.78 % 11.4 % 8.98 % 5.28 %

CELG Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q3 MRQ) 56.28 % -0.43 % -20.39 % -9.43 %
Q / Q Net Income Growth (Q3 MRQ) 7.64 % 3.01 % -17.21 % -10.44 %
Y / Y Net Income Change (Q3 TTM) 103.32 % 75.19 % 67.04 % 13.57 %
Sequential Net Income Change (Q3 TTM) 11.55 % -0.28 % -5.45 % -0.96 %
Net Income 5 Year Avg. Growth 22.78 % 0.15 % 2.63 % 8.91 %

CELG's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q3 MRQ) 54.55 % 47.76 % -14.81 % -6.67 %
Sequential EPS from Cont. Ops. Change (Q3 MRQ) 7.21 % 607.73 % -11.95 % -5.84 %
Y / Y EPS from Cont. Ops. Change (Q3 TTM) 105.96 % - - -
Sequential EPS from Cont. Ops. Change (Q3 TTM) 11.26 % - - -4.07 %
EPS from Cont. Ops. 5 Year Avg. Growth 26.42 % -1.95 % 8.98 % 5.28 %



CELG EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q3 MRQ) 54.67 % 45.93 % -20.39 % -9.43 %
Q / Q EPS Net Growth (Q3 MRQ) 7.41 % 604.56 % -17.21 % -10.44 %
Y / Y EPS Net Change (for 12 months ending Q3 TTM) - - - 54.62 %
Sequential EPS Net Change (for 12 months ending Q3 TTM) 11.29 % - 685.49 % -1.68 %
EPS Net 5 Year Avg. Change 26.81 % 0.15 % 2.63 % 8.91 %



Celgene showed respectable 54.67% year on year rise of EPS in the third quarter, comparing favorably to the 45.93% increase in the Major Pharmaceutical Preparations industry, and -20.39% decline in the Healthcare sector. Comparing the third quarter income per share growth, both Major Pharmaceutical Preparations industry and Celgene Corp outperformed -9.43% overall market increase.

Comparing company's EPS to the second quarter results, income per share were higher by 7.41% . On the yearly basis, average annual income per share growth for Celgene is 26.81%, while S & P 500's including only the businesses with the third quarter 2019 Results, average annual income per share growth is 8.91% over the past five years.

CELG Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q3 MRQ) -8.39 % 14.08 % 13.76 % -8.89 %
Sequential Free Cash Flow Change (Q3 MRQ) -19.13 % 53.12 % 52.68 % 17.34 %
Y / Y Free Cash Flow Change (Q3 TTM) 78.46 % -8.32 % -4.69 % -9.42 %
Sequential Free Cash Flow Change (Q3 TTM) -2.05 % 3.73 % 4.11 % -2.15 %
Free Cash Flow 5 Year Avg. Change 18.33 % 10.79 % 9.24 % 32.11 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q3 MRQ) 144.63 % 131.91 % 230.49 % -
Sequential Net Cash Flow Change (Q3 MRQ) 34.19 % -58.41 % 47.53 % -
Y / Y Net Cash Flow Change (Q3 TTM) - 445.83 % 551.93 % -
Sequential Net Cash Flow Change (Q3 TTM) - -4.82 % 7.21 % -
Net Cash Flow 5 Year Avg. Change - 116.02 % 59.89 % -

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q3 MRQ) 631.25 % 23.46 % 20.6 % 1.72 %
Sequential Capital Expenditures Change (Q3 MRQ) 680 % 16.24 % 10.52 % -4.36 %
Y / Y Capital Expenditures Change (Q3 TTM) 107.46 % 18.72 % 10.21 % 3.94 %
Sequential Capital Expenditures Change (Q3 TTM) 138.83 % 5.85 % 3.58 % 2.86 %
Capital Expenditures 5 Year Avg. Change 22.49 % 7.86 % 7.59 % -17.93 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.